Under the CMEA, the substance specifically monitored is pseudoephedrine, which can be used to produce methamphetamine. Other substances mentioned, such as guaifenesin, naphazoline, and dextromethorphan, are not specifically targeted by this legislation. The CMEA implements restrictions on product sales to prevent misuse. ;
Under the CMEA, the substance specifically monitored is pseudoephedrine due to its potential use in methamphetamine production. The act requires restrictions on its sale, including identification checks and purchase limits. Other substances mentioned, like guaifenesin and dextromethorphan, are not targeted by this legislation.
;